Prognostic Factors for Pancreatic Cancer Patients Treated with Immune-cell Therapy

The past 17 years, immune-cell therapy has been administered to 990 patients with advanced or recurrent pancreatic adenocarcinoma and 50 patients with curatively resected pancreatic adenocarcinoma. The correlation between overall survival (OS) and various factors including sex, age, performance stat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anticancer research 2018-07, Vol.38 (7), p.4353-4360
Hauptverfasser:	Makita, Kaori, Kamigaki, Takashi, Okada, Sachiko, Matsuda, Eriko, Ibe, Hiroshi, Oguma, Eri, Naitoh, Keiko, Takimoto, Rishu, Goto, Shigenori
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Adenocarcinoma - mortality Adenocarcinoma - therapy Adult Aged Aged, 80 and over Cancer Cancer Vaccines - therapeutic use Chemotherapy Combined vaccines Confidence intervals Dendritic cells Dendritic Cells - transplantation Disease-Free Survival Female Humans Kaplan-Meier Estimate Lymphocytes Lymphocytes T Male Medical prognosis Metastases Metastasis Middle Aged Multivariate analysis Pancreatic cancer Pancreatic Neoplasms Pancreatic Neoplasms - mortality Pancreatic Neoplasms - therapy Patients Prognosis Proportional Hazards Models Radiation therapy Retrospective Studies Survival T-Lymphocytes - transplantation Treatment Outcome Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!